ASTELLAS PHARMA UNSP.ADR (YPHA) — Net Asset Momentum
ASTELLAS PHARMA UNSP.ADR (YPHA) recorded a net asset momentum of -5.2% as of March 2025, with net assets of €1.51 Trillion EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See shareholders equity of ASTELLAS PHARMA UNSP.ADR for net asset value and shareholders' equity analysis.
YoY Momentum
Current Net Assets
Years of Data
Country
ASTELLAS PHARMA UNSP.ADR Net Asset Momentum (2022–2025)
This chart tracks ASTELLAS PHARMA UNSP.ADR's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is -5.2%, with net assets of €1.51 Trillion EUR as of March 2025. For live market cap and overall valuation, see YPHA company net worth.
Annual Net Asset History for ASTELLAS PHARMA UNSP.ADR (2022–2025)
The table below shows the complete annual net asset history for ASTELLAS PHARMA UNSP.ADR from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. Check how tangible is ASTELLAS PHARMA UNSP.ADR's equity to evaluate the tangible quality of the company's equity base.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €1.51 Trillion | €3.34 Trillion | €1.83 Trillion | ▼ -5.2% |
| 2024 | €1.60 Trillion | €3.57 Trillion | €1.97 Trillion | ▲ +5.8% |
| 2023 | €1.51 Trillion | €2.46 Trillion | €948.56 Billion | ▲ +3.3% |
| 2022 | €1.46 Trillion | €2.33 Trillion | €872.09 Billion | — |